133 related articles for article (PubMed ID: 8321364)
1. Comparative nephrotoxicity of tetraplatin and cisplatin in rats.
Rahman A; Roh JK; Preuss HG
Nephron; 1993; 64(2):289-95. PubMed ID: 8321364
[TBL] [Abstract][Full Text] [Related]
2. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.
Smith JH; Smith MA; Litterst CL; Copley MP; Uozumi J; Boyd MR
Fundam Appl Toxicol; 1988 Jan; 10(1):45-61. PubMed ID: 3350229
[TBL] [Abstract][Full Text] [Related]
3. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
Smith MA; Smith JH; Litterst CL; Copley MP; Uozumi J; Boyd MR
Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230
[TBL] [Abstract][Full Text] [Related]
4. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Carfagna PF; Chaney SG; Chang J; Holbrook DJ
Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
[TBL] [Abstract][Full Text] [Related]
5. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation.
Kawai Y; Taniuchi S; Okahara S; Nakamura M; Gemba M
Biol Pharm Bull; 2005 Aug; 28(8):1385-8. PubMed ID: 16079479
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices.
Kameyama Y; Okazaki N; Nakagawa M; Koshida H; Nakamura M; Gemba M
Toxicol Lett; 1990 Jun; 52(1):15-24. PubMed ID: 2356567
[TBL] [Abstract][Full Text] [Related]
7. The nephrotoxicity, cytotoxicity and renal handling of a cisplatin-methionine complex in male Wistar rats.
Deegan PM; Pratt IS; Ryan MP
Toxicology; 1994 Mar; 89(1):1-14. PubMed ID: 8178319
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
Rahman A; Roh JK; Wolpert-DeFilippes MK; Goldin A; Venditti JM; Woolley PV
Cancer Res; 1988 Apr; 48(7):1745-52. PubMed ID: 3162402
[TBL] [Abstract][Full Text] [Related]
9. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats.
Scott LA; Madan E; Valentovic MA
Toxicology; 1990; 60(1-2):109-25. PubMed ID: 2107603
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Loh SY; Abel G; Murrer BA; Harrap KR
Cancer Res; 1992 Nov; 52(22):6188-93. PubMed ID: 1423261
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the renal endoplasmic reticulum calcium pump: a possible biomarker for platinate toxicity.
De Witt LM; Jones TW; Moore L
Toxicol Appl Pharmacol; 1988 Feb; 92(2):157-69. PubMed ID: 2963406
[TBL] [Abstract][Full Text] [Related]
12. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
Kim WK; Kwon YE
Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
Hannemann J; Baumann K
Arch Toxicol; 1990; 64(5):393-400. PubMed ID: 2169720
[TBL] [Abstract][Full Text] [Related]
14. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
Engineer MS; Brown NS; Ho DH; Newman RA; Bulger RE
Toxicology; 1989 Dec; 59(2):151-62. PubMed ID: 2588264
[TBL] [Abstract][Full Text] [Related]
17. Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat.
McKeage MJ; Boxall FE; Jones M; Harrap KR
Cancer Res; 1994 Feb; 54(3):629-31. PubMed ID: 8306321
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of tetraplatin and cisplatin for human and rodent cell lines cultured as monolayers and multicellular spheroids.
Bhuyan BK; Folz SJ; DeZwaan J; Northcott SE; Alberts DS; Garcia D; Wallace TL; Li LH
Cancer Commun; 1991 Feb; 3(2):53-9. PubMed ID: 1995028
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys.
Miura K; Goldstein RS; Pasino DA; Hook JB
Toxicology; 1987 May; 44(2):147-58. PubMed ID: 3564050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
